Macrogenics (MGNX)

$29.49 0.61 (2.11%)
16:00 EDT MGNX Stock Quote Delayed 30 Minutes

Why MacroGenics Stock Is Soaring Today

MacroGenics Inc (MGNX) is surging today after solid Phase-III trial results on its later-stage breast cancer treatment. Should you buy MGNX stock?

athenahealth, Inc (ATHN), Yelp Inc (YELP) Leads Today’s Top 30 Investor Filings

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 1.77B
PE Ratio -11.80
EPS -2.5
Volume (Avg. Vol.) 632,574
Day's Range 28.57 - 29.65
52-Week Range 18.16 - 36.48
Dividend & Yield N/A (N/A)